Research and diagnostic of Malian, infectious and rare metabolic diseases based on MDI TOF technology (Q2727791)

From EU Knowledge Graph
Revision as of 13:25, 21 June 2021 by DG Regio (talk | contribs) (‎Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string)
Jump to navigation Jump to search
Project Q2727791 in Croatia
Language Label Description Also known as
English
Research and diagnostic of Malian, infectious and rare metabolic diseases based on MDI TOF technology
Project Q2727791 in Croatia

    Statements

    0 references
    13,709,670.59 Croatian kuna
    0 references
    1,782,257.18 Euro
    2 June 2021
    0 references
    16,129,024.22 Croatian kuna
    0 references
    2,096,773.15 Euro
    2 June 2021
    0 references
    85.0 percent
    0 references
    28 May 2018
    0 references
    1 October 2019
    0 references
    Klinički bolnički centar Osijek
    0 references
    Q2758254 (Deleted Item)
    0 references

    45°33'17.86"N, 18°41'43.84"E
    0 references
    31000
    0 references
    Projektom će se riješiti problemi prijavitelja vezani uz nedostatne tehnološke kapacitete Odjela za kliničku kemiju KBC-a Osijek te postići cilj koji se odnosi na unapređenje znanstvene izvrsnosti u sektoru biomedicine i zdravstva u RH uvođenjem MALDI TOF MS tehnologije. Realizacija projekta zadovoljit će potrebe ciljnih skupina, dok će se rezultati istraživanja preusmjeriti na pružanje potpore gospodarstvu, prije svega osiguranicima HZZO-a, dijagnostičkoj i farmaceutskoj industriji. Dodatno, društvena vrijednost realizacije projekta je unaprijeđena zdravstvena zaštita i nastavna djelatnosti. (Croatian)
    0 references
    The project will address the applicants’ problems linked to the lack of technological capacities in the KWC Unit for Clinical Chemistry, and achieve the objective of improving scientific excellence in the biomedical and health sector in Croatia through the introduction of MalDI TOF MS technologies. The realisation of the project will meet the target group needs, while the results of the research will be redirected to supporting the economy, notably by HZZO, the diagnostic and pharmaceutical industry. In addition, the social value of the realisation of the project has improved health care and teaching activities. (English)
    3 June 2021
    0 references

    Identifiers

    KK.01.1.1.02.0015
    0 references